Podcasts about Dispensing

Effective February 19, 2026, New York State law permits clinicians to dispense up to 72 hours (equivalent to a 3-day supply) of controlled substances, such as methadone and buprenorphine, for the management of opioid withdrawal while arranging referral and linkage to care for persons with opioid use disorder, as authorized by federal regulations (specifically, the Code of Federal Regulations or CFR number 1306.07). The federal regulations were updated in August 2023, and New York State law is just now catching up. We informally refer to the update as “The 72-Hour Rule.” Featuring Dr. Linda Wang, this episode reviews what this update means for New York State and how clinicians and healthcare administrators can think about its implementation. Are you implementing “The 72-Hour Rule” in clinical practice in New York State? We want to hear from you! Please reach out to share your experience: Lauren.walker3@mountsinai.org. Related Content:  New York State Senate Bill S3416D: https://www.nysenate.gov/legislation/bills/2025/S3416/amendment/D Code of Federal Regulations (CFR) § 1306.07: https://www.ecfr.gov/current/title-21/chapter-II/part-1306/subject-group-ECFR1eb5bb3a23fddd0/section-1306.07 Skogrand E, et al. (2024). Dispensing methadone at hospital discharge: One hospital's approach to implementing the “72-hour rule” change. J Addict Med. 2024; 18(1):71-74. doi: 10.1097/ADM.0000000000001246. Shahlapour M, et al. (2024). Novel uses of methadone under the “72-hour rule” to facilitate transitions of care and low-dose buprenorphine induction in an outpatient bridge clinic. J Addict Med. 2024; 18(3):345-347. doi: 10/1097/ADM.0000000000001281. Taylor JL, et al. (2022). Bridge clinic implementation of "72-hour rule" methadone for opioid withdrawal management: Impact on opioid treatment program linkage and retention in care. Drug Alcohol Depend. 2022; 236:109497. doi: 10.1016/j.drugalcdep.2022.109497. CEI Clinical Consultation Line 1-866-637-2342 A toll-free service for NYS clinicians offering real-time clinical consultations with specialists on HIV, sexual health, hepatitis C, and drug user health. https://ceitraining.org/

Send a text“HB 495: Dispensing Practitioner Status — Restoring Common Sense to Dentistry”It took months of discussions, revisions, and clarifications, but in 2025, Utah passed HB 495, officially adding dentists to the list of approved dispensing practitioners. Support the show

Degens Andy S and Brandon Bombay are out for vengeance as they discuss a movie that launched a thousand imitators, 'Death Wish.' Andy kicks off the episode by telling a recent tale when his car was hit in a hit and run, and he decided to dole out some justice. Then the fellas talk about this Charles Bronson classic that borders on exploitation, and is super dark even by '70s studio standards. No one can blame Bronson's Paul Kersey for snapping after his wife with the "prime figure" is murdered by thugs, and the doctor delivers the news in hilariously uncouth fashion. Seeing Bronson run the streets with his gun, inspires the boys to perhaps buy some for themselves, and how that could be a horrible idea. Even for a podcast that welcomes degenerate behavior it's obvious that Bronson's bloodlust is unsustainable, as he continues killing while knowing that the police are watching him. Overall, it's a bonkers episode that will leave listeners acting like Jeff Goldblum's Freak #1 when they're finished.

Today, I'm joined by someone who has spent more than three decades at the intersection of materials science, automation, and high-reliability manufacturing. Jon Urquhart is the Director of Global Applications Engineering at Precision Valve and Automation — one of the world's leading developers of dispensing, coating, and industrial motion-automation systems. Since joining PVA in 1993, Jon has become widely recognized for his expertise in fluid material processing, precision dispensing, and the engineering-to-manufacturing handoff that so often makes or breaks product reliability.Jon holds multiple patents and has helped shape advanced processes used in industries where the stakes couldn't be higher — from aerospace and EV battery systems to semiconductor packaging, medical devices, and high-density electronics assembly. His work spans everything from protective coatings that safeguard electronics in extreme environments, to next-generation thermal interface material (TIM) deposition, to automation strategies that reduce human error, improve consistency, and dramatically scale production.We'll discuss the real-world challenges of protecting critical electronics and batteries, the latest advances in TIM materials and deposition, sustainable precision-coating techniques, and the power of a strong collaboration model between vendors, manufacturers, and lab technicians.PVA Website:https://www.pva.netJon Urquhart:jurquhart@pva.net

Jon Urquhart is director of global applications engineering at Precision Valve and Automation — one of the world's leading developers of dispensing, coating, and industrial motion-automation systems. Since joining PVA in 1993, Urquhart has become widely recognized for his expertise in fluid material processing, precision dispensing, and the engineering-to-manufacturing handoff that so often makes or breaks product reliability. Urquhart holds multiple patents and has helped shape advanced processes used in industries where the stakes couldn't be higher — from aerospace and EV battery systems to semiconductor packaging, medical devices, and high-density electronics assembly. His work spans everything from protective coatings that safeguard electronics in extreme environments, to next-generation thermal interface material (TIM) deposition, to automation strategies that reduce human error, improve consistency, and dramatically scale production. He joins Mike Konrad to discuss the real-world challenges of protecting critical electronics and batteries, the latest advances in TIM materials and deposition, sustainable precision-coating techniques, and the power of a strong collaboration model between vendors, manufacturers, and lab technicians.

Justice ~ Which is more important in dispensing justice; rewards or punishment? A short interview with Dr Tara Smith. Listen to caller's personal dramas four times each week as Dr. Kenner takes your calls and questions on parenting, romance, love, family, marriage, divorce, hobbies, career, mental health - any personal issue! Call anytime, toll free 877-Dr-Kenner. Visit www.drkenner.com for more information about the show (where you can also download free chapter one of her serious relationships guidebook).

In this episode, we speak with Dr Sam Patel, National Programme Lead for the Digital Prescribing and Dispensing Pathways (DPDP) Programme, to explore Scotland's progress toward replacing paper prescriptions with a secure, end-to-end electronic system. Sam explains the legal and technical foundations required to make the transition — from implementing advanced electronic signatures compliant with UK and EU standards, to the key legislative amendments for the programme. We discuss how Scotland's infrastructure differs from England's EPS “Spine” system and how the new approach, built on the National Digital Platform, will need to support national identity verification, secure messaging, and audit capability across GP and pharmacy systems. Looking ahead, Sam outlines the project's timeline, challenges, and expected benefits. The first pilot sites are targeted for late 2028, following the appointment of a delivery partner and integration with new GPIT and pharmacy systems. We discuss the enormous potential for reducing admin time, improving patient convenience, and creating better repeat-prescribing processes — all while ensuring those who are less digitally enabled aren't left behind. We also touch on moves towards a consolidated medication record, ECS replacement and the Digital Front Door plans for Scotland. About the Digital Prescribing and Dispensing Pathways (DPDP)    DPDP Animation NHS Scotland National Digital Platform (NDP) Human Medicines Regulations 2012 (legislation.gov.uk) Electronic Communications Act 2000 Community Pharmacy Scotland SNUG – Scottish National Users Group   Queries and comments to: alex.defranco@phs.scot Agenda for SNUG Virtual Conference        Register here

Support the Roman Forum: https://www.romanforum.org/What is the Roman Forum: https://youtu.be/gwNSwFUsd7ARoman Forum 2025 Playlist https://www.youtube.com/playlist?list=PL68P1D5BPUmelJajzKn_Oz8_b1EBGCeqDFollow us on Rumble! https://rumble.com/c/c-390435Twitter: https://x.com/CFNonX#catholic #traditionallatinmass #traditionalcatholic #sspx #latinmass #fssp

It feels odd to say we have reached a lull in off-season because well...it is the off-season but with the announcement of the PNG Chiefs and the Prime Minister's XIII games behind us we do have something of a down week in an otherwise frenetic off-season. The Tip Sheet still rattles on without any brakes to cover the latest from Parramatta and the wider NRL. How did the representative Eels fare on the weekend? With junior and senior talent in action across both Australian and Papua New Guinean squads. Was Mitchell Moses able to navigate a shock late call up (down?) onto the PM XIII bench? Jonah Pezet is the hottest name on the player market right now after activating a clause that makes him a free agent. Where exactly do Parramatta fit into the frame with the Melbourne playmaker? The action does ramp up on the weekend thankfully with the first round of the Pacific Championships. How does each side shape up? Meanwhile there have been some player and coaching transactions across the NRL as teams look to rebuild, reshape or reload ahead of the 2026 season.

Nevo Hadas – CEO, Smartfill SAfm Market Update - Podcasts and live stream

In this episode, Eric Huckins, Vice President of Business Development at Lumicera Health Services, discusses how health systems can build stronger specialty pharmacy programs by navigating challenges such as 340B, payer access, and accreditation. He also highlights the role of strategic partnerships, biosimilars, and technology in improving patient care and driving growth.This episode was sponsored by Lumicera Health Services.

2 - Corey DeAngelis, School Choice Evangelist, joins us today. What is Corey's take on why Josh Shapiro sided with the unions in the 11th hour as far as budgeting negotiations go? Why is this school choice bill similar to the federal drinking age being 21? Where do we stand with integrating AI into education? Why do Democrats continue to wage a war against homeschooling? 215 - Dom's Money Melody! 225 - Is the Babylon Bee correct in its satire of the “Phillies Karen”? 230 - Will speeding cameras really prevent crime in Philadelphia? Are the red light cameras even working? 240 - Your calls. Breaking News: Charlie Kirk was shot at it in Utah. 250 - The Lightning Round!

This week Emma speaks to Dr Richard West, a GP partner in a dispensing practice in Suffolk and chair of the Dispensing Doctors' Association.Dispensing practices are a vital lifeline for patients in rural areas, but they are facing a host of challenges that are threatening their viability. In this conversation, Richard explains the crucial role these practices play and the immense pressures they are under.Richard talks through the complexities of dispensing practice funding, highlighting how out-of-date fee scales and unreimbursed drug costs are affecting practices and what the Dispensing Doctors' Association is campaigning for to ensure these essential services survive.He also discusses what needs to change in the GP contract to support dispensing practices, the impact drug shortages have on staff and patients and the need to ensure that ways of working envisaged in the 10 year plan are designed to work for rural populations.This episode was presented by GPonline editor Emma Bower. It was produced by Czarina Deen.Useful linksDispensing Doctors' AssociationDispensing Doctors' Association RAMP UP campaignMIMS - Drug shortages - live trackerMPs demand major review as UK medicine shortages now 'daily reality' Hosted on Acast. See acast.com/privacy for more information.

Sarah Isgur and David French discuss the use of autopens as a permission structure and David's Very Big Problems with technology and the pardon power. —What is an autopen?—The problems with David's problems—Buckets of pardons—Day 182 of ignoring the TikTok law—Dispensing power vs. autopen power—Bullying our way to cultural victory—Mandatory reporting and Catholic priests—Responding to Supreme Court clerks—TL;DR concurrence Show Notes:—New York Times article on Biden's pardons—McMahon v. New York—Andy Smarick's piece for The Dispatch—Bob Bauer piece on progressives This episode is brought to you by Burford Capital, the leading global finance firm focused on law. Burford helps companies and law firms unlock the value of their legal assets. With a $7.2 billion portfolio and listings on the NYSE and LSE, Burford provides capital to finance high-value commercial litigation and arbitration—without adding cost, risk, or giving up control. Clients include Fortune 500 companies and Am Law 100 firms, who turn to Burford to pursue strong claims, manage legal costs, and accelerate recoveries. Learn more at burfordcapital.com/ao. Learn more about your ad choices. Visit megaphone.fm/adchoices

Prescriber-Level Changes in Buprenorphine Dispensing in the USA Before and After Federal Policy Changes Aimed at Increasing Prescribing Journal of General Internal Medicine This study used interrupted-time-series analysis to model prescriber-level trends in buprenorphine prescriptions after recent federal policy changes.  It found that the elimination of the waiver requirement to prescribe buprenorphine in December 2022 was associated with a significant increase in the number of buprenorphine prescribers, but a decrease in the mean number of patients and the mean number of prescriptions per prescriber. Changes in telehealth flexibilities and relaxed training requirements were largely not associated with prescribing changes. This study expands on prior research by providing further insight as to why waiver elimination has not increased the number of patients receiving buprenorphine, as expected.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Medicaid Unwinding and Changes in Buprenorphine Dispensing  JAMA Network Open Among Medicaid-insured adults with buprenorphine use, this cross-sectional study examined if changes in buprenorphine dispensing were greater among those residing in states with the highest vs lowest decreases in Medicaid enrollment after “Medicaid unwinding” began in April 2023. Researchers used 2017-2023 data from a national prescription dispensing database that included 754,675 person-years from 569,069 patients. They found that patients in states with the highest decreases in Medicaid enrollment were more likely to decrease buprenorphine use, discontinue buprenorphine therapy, and use private insurance or cash to pay for buprenorphine prescriptions. The finding that Medicaid unwinding was associated with disruptions in buprenorphine therapy raises concerns about the potential for increased opioid-related morbidity and mortality.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

In this episode Sue Kressly, MD, FAAP, discusses what new federal cuts to health care mean for children. Hosts David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, also talk to Kao-Ping Chua, MD, PhD, FAAP, about changes in chronic medication dispensing to children and young adults during Medicaid unwinding. For resources go to aap.org/podcast.

Dr. Luis Raez and Michael Reff share the newest update to the medically integrated dispensing pharmacy standards from NCODA and ASCO. They review updates to domain one, on key patient-centered quality standards on health equity and social determinants of health, drug access, patient safety, education, and adherence to maximize treatment outcomes and domain two, on key operational quality standards on logistics, care coordination, and waste prevention. We also cover the impact of these updated standards for clinicians, oncology practices, and people receiving oral anti-cancer medications. Read the complete standards, “Medically Integrated Dispensing Pharmacy: ASCO-NCODA Standards.” Transcript These standards, clinical tools, and resources are available on ASCO.org.  Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the JCO Oncology Practice. Brittany Harvey: Hello, and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts.  My name is Brittany Harvey, and today I'm interviewing Michael Reff from the Network of Collaborative Oncology Development and Advancement and Dr. Luis Raez from Memorial Cancer Institute and Florida Atlantic University, co-chairs on "Medically Integrated Dispensing Pharmacy: American Society of Clinical Oncology – Network of Collaborative Oncology Development and Advancement Association Standards Update." Thank you for being here, Michael and Dr. Raez. Dr. Luis Raez: Thanks for inviting us. Michael Reff: Thank you for having us. Brittany Harvey: Then, before we discuss these standards, I'd like to note that ASCO takes great care in the development of its standards and ensuring that the ASCO Conflict of Interest policy is followed for each guidance product. The disclosures of potential conflicts of interest for the expert panel, including Michael and Dr. Luis Raez who have joined us here today, are available online with the publication of the standards in JCO Oncology Practice, which is linked in the show notes. So then, to dive into the content here, Michael, I'd like to start with what prompted an update to these ASCO-NCODA standards and what is the scope of this update? Michael Reff: Thank you, Brittany. What led NCODA and ASCO to endeavor in this, and it started back in 2019 as the amount of oral anticancer medications became more and more prevalent in cancer treatment, we saw the need providing a blueprint for excellence in care for patients prescribed oral anticancer medications, specifically in the outpatient setting. And the update was driven by the rapid growth of these oral oncolytics starting back in the mid to late 2015 through 2019 or so, and then continued on into the 2020s where we are today. We saw the increase in the complexity of the management of these patients with these therapies basically outside the traditional clinical settings. And we wanted to make sure that with more cancer treatments that are taken at home than just at the clinic, like in the oral setting, new challenges had emerged around patient safety, access, adherence, and overall treatment success. The updates now address patient-centered and operational interventions designed to improve access, safety, quality, accountability, and outcomes of oral anticancer and other supportive care medications prescribed for the cancer patient. Dr. Luis Raez: As Mike said, these guidelines help improve patient care tremendously, but also help us a lot as an oncologist, you know, community oncologists that- now that we have opportunity to dispense these oral oncolytics, we need help to create our medical integrated pharmacies, and NCODA is providing here a way that, how to do this safely, efficaciously, good quality, you know? So that's why I think we always do everything for the patients, but also this helps a lot to the doctors. And there are a lot of what we call specialty pharmacies or medical integrated pharmacies now nationwide. Michael Reff: I'll build on what Dr. Raez had mentioned. This is the impetus. If you looked at the innovation that was coming from the pharmaceutical companies, many of it coming in the oral form for anticancer medications, and based on that, taking a look at the infrastructure that is in place in these practices, whether it's in the community or the IDN or health system settings, this amount of innovation that was coming needed to be addressed by taking a look at the medically integrated oncology team. And these standards address not just the pharmacy component, but also the whole continuum of care, starting with a medical oncologist or the hematologist, with the pharmacists, nurses, the pharmacy technicians, others that are involved in the care of the patient. And there were no standards involved. And when we approached ASCO back in 2018 to eventually publish the first version of these standards, the need was identified, and we worked collaboratively with ASCO to create the first set and then the revisions as we talked about. One thing to note regarding the revision plus the original standards, we had a cross-section of the care team on the committee, and we did that very purposefully. So, the ASCO-NCODA team curated a committee to help develop these original standards and the revision of these standards with medical oncologists both from community and health systems, pharmacists from both community and health systems, and also nurses. And we also included a patient that currently has and currently receives oral anticancer medication. And so NCODA and ASCO are very proud of the committee that we put together because of the experts in their field, but also extended the invitation to a current patient. And we embedded everybody's expertise in the curation of these standards. Brittany Harvey: Absolutely. I appreciate that background and context and how it's critical to improve patient care. And these standards really help oncologists, and we're looking across the continuum of care to provide optimal care for our patients. So then next, Dr. Raez, I'd like to review the key points of the revised standards for our listeners. So for Domain 1, what are the key patient-centered quality standards on health equity and social determinants of health, drug access, patient safety, education, and adherence to maximize treatment outcomes? Dr. Luis Raez: Yeah, this was a great effort, you know, at the multidisciplinary team. And as you can read in the standard, there were more than 240 publications reviewed; more than 55 of them are quoted here. And the standards are in two groups, as you said. With the group one, I'll briefly mention some of them. For example, SDOH, social determinants of health, is very important because as doctors, we prescribe, and sometimes patients don't get the medication, you know? And we prescribe assuming that 100% of the patients will get the medication. But something simple like the patient doesn't have insurance, the patient is underinsured. I have a patient that we didn't have an address to send the medication because he's homeless. Something that as a doctor you say, "Oh, oh my God, this is outside my realm," but it's not outside reality. So that's why, even if we don't think that this is part of our expertise dealing with social determinants of health, the fact that the patients have food insecurity, they don't have transportation, they don't have insurance, they don't have a caregiver, impact tremendously in the outcomes of the therapy. So that's why, basically, in this standard, we want to call attention that SDOH, social determinants of health, needs to be identified. There are in the literature countless examples of why this is important. For example, in the guidelines, we quote two or three examples of prostate cancer studies that, for example, we quote a study of 27,000 people with prostate cancer that were taking oral oncolytics, and how come the fact that the elderly, seniors, the fact that they have high prescription costs, and how all of this affected the adherence to the medication. And that's why it's important to identify the SDOH. And in other sections of the guidelines, we said how to address them, no? Another important thing in this domain is the cultural, you know, we need to be culturally sensitive and to take care of all of these social factors. For example, here in South Florida, we deal with the Haitian culture, Filipino culture, Latin culture, and American culture, and it's a blend, but it's not easy to go from one to the other. Another one is the fact that we have to include new technologies. A lot of patients, for example, we use EMR, EMR Epic, and now Epic has everything in the phone. The fact that we can have now the patient can see her prescription medication over the phone, the fact that they can use the phone to request from you a refill, and from your phone, you send the refill to the pharmacy, and you notify from your phone to the patient that the refill is sent, and the patient can check in his phone that the refill is ready. These things are amazing because that's why it's important that we incorporate these technologies to the patient care, and in this specific case, of dispensation of oral therapies, no? Another crucial point is education. You cannot be sending a patient a package of 300 pills without education. So that's why in our guidelines, mainly pharmacy, clinical pharmacies, or in some centers like mine, we have advanced practice providers, it's mandatory in our centers to have like a one hour of education before you send the prescription. So the patient is aware about side effects and contraindications, all of these things. They provide them also materials and also consent. You know, in the old times, you don't give chemo without a consent. Now, a lot of people say, "Oh, it's only a pill." There is a lot of benefits or side effects that can come from the pill, so you need to consent everybody, you know? So, another aspect is adherence. I already told about that, but we need to provide patients with a baseline assessment, no? So, you cannot send again the prescription and hope, "Oh, I'll figure it out what happened next month when the patient comes back." I tell you, the patient is homeless, where are you going to send it? If the patient is telling you, "I don't have insurance," what good is it for you to send a prescription? The patient will not get it. So that's why you need to do a baseline assessment of adherence. You need to do a calendar. You need to do electronic support, I mentioned already with the EMR and the phones. For example, my MIP, my specialty pharmacist, sends me a message in the EMR, "Dr. Raez, the insurance is not covering, the patient has a high copayment, we are going to delay the dispensation of the medication." So there needs to be a communication. Or sometimes there is a confusion with the insurance, and I cannot wait for the poor patient to call three, four weeks later, "Oh, I didn't get the medication," to know what happened, no? My MIP is very good. They send the clinical pharmacist a message, "Hey, you know, the insurance doesn't believe that the pill is adequate, or you need to provide more documentation. You need to prove the mutation, the genetic aberration." So if you provide us that, the insurance may approve. So that communication with the doctor is very important to improve adherence. And one important thing that we have in this one that we didn't have in the anterior is the tracking of outside medications. A lot of times you say, "Okay, the insurance allowed us to provide the medication it's 100% responsible." But then the insurance says, "Oh, no, no, don't worry. CVS will provide the medication." So it says, "Well, it's you know, it's not my responsibility. CVS will provide the medication, they have to take care." But we know that outside our specialty pharmacies or MIPs, the care is not very good. So that's why we are taking our ownership that, "Okay, the insurance said the patient will get the medication from some outside pharmacy." But our clinical pharmacists track that. What happened? Did the patient get it? The patient didn't get it. The copayment is still high. So even if you get the medication from somewhere else, if the copayment is high, we, our clinical pharmacists, help the patient to navigate and get the foundation or the copayment or finally the maker, the industry partner, provides the drug for free, but somebody needs to do the paperwork. And that's why this is very important. We cannot abort our responsibility because, "Oh, the insurance said somebody else will give it." I work for the public healthcare system, so my patients, some of them don't have insurance, they are underinsured. So we see these problems every day. And finally, the standards talk about the importance of safety, documentation, verification, monitoring, refills, you know, you need to keep track of refills. We already mentioned how important is the technology to facilitate the refills, and the quality. Brittany Harvey: Yes, thank you for touching on those highlights for Domain 1. It's important that all patients have access to care and these oral anticancer medications, and not only just access to care, but safe and effective care. It's really important, as you mentioned, Dr. Raez, to meet patients where they're at and incorporate technology. And I also want to note the coordination with external pharmacies that you mentioned in tracking outside medications as well. It's not only important for multidisciplinary care within the oncology practice itself, but also external to the oncology practice. That's why we put together this multidisciplinary panel to develop these standards. So then, expanding on that, Dr. Raez, for Domain 2, what are the key operational quality standards? Those on logistics, care coordination, and waste prevention. Dr. Luis Raez: Yeah, we have a lot of standards here, but maybe we can summarize in five or six points, no? For example, financial toxicity in cost and waste are very important because the patients, yeah, you put them on therapy, but as you can understand, if there is disease progression, the patient don't need the medications. And sometimes you get refills even if the patient has disease progression. If you do a dose reduction, the same problem. Or you discontinue medication and the patient keeps getting the drugs. So, you're talking about drugs that are between 20 and 30 thousand dollars per month. This is a lot of money. There are studies that we're quoting in the standards that the waste could be from 1 to 3 or 4 thousand per patient, no? Another aspect is dispensing. When you dispense the medication, this is not as easy as, "I'll ship to your house a bag of medications." You know, there needs to be a diagram, a decision tree. You need to train the staff to know what we're doing. There needs to be an auditing of the process. They need to be even packaging and shipping, you know? For example, I'm in Florida today and outside in summer it's going to be 95 degrees. So, everybody leaves the package outside your house, and sometimes you go the whole day until when you come at 6:00 p.m. There are medications that cannot be left outside there, you know? I don't know, it sounds like a joke, but I have a patient that the medication used to be stolen because people thought that that was something important, you know? And of course, it's important because it's a $20,000 medication. So, the poor patient, because he lives in an area that is not safe, has to come and pick up in person. All of these things sound very trivial, but that's real life that affects adherence. Another important thing is shortage. This is something that we just suffered two or three years ago, and we have to think about what happens in the next shortage. What happens if there's going to be a shortage? What do we do or how are we going to do that? Now we know it's something that is happening probably very soon again, and something that we have to consider. Another standard is the care coordination. You need to have probably, if it's possible, a coordinator. I know that for small practices it's very hard, but for big cancer centers, you should have a coordinator of this. I already mentioned before, the communication between the physicians and the doctors to coordinate the care, no? You need to write the prescription again, you need to provide more information, or to be notified, "Hey, you know, the patient is throwing up in the first week, you need to see the patient, please," no? So, this type of communication needs to exist so we can serve the patient better. It's also important, you know, we're improving quality and we're improving care. It's important to try to collect patient-reported outcomes. This is something that now we have the opportunity, if we do things well, to do it and show that we're providing a better care. The other thing is that we already mentioned SDOH in the other standard. In this standard, we mention mainly SDOH to partner. For example, we collect in my center SDOH, and I always get frustrated when the patient doesn't have transportation. But I didn't know that there are local institutions that provide free Uber rides, free Lyft rides. So that's why it's important to partner with these institutions. I have a local grocery chain that provides free food for the patients, and I didn't know that. It's important to be aware what the patient needs and what resources do you have to fulfill the SDOH. That's the part that we mention in here. So that's why, in summary, those are the six probably most important points here. I'll ask Mike for some comments. Michael Reff: Thank you, Dr. Raez. Brittany, to answer your question, and as was pointed out on logistics, care coordination, and prevention of waste, certainly that is an aspect that has changed in the revision that we're here to talk about. There's really two components to waste, and it's cost avoidance and then waste prevention. And as Dr. Raez mentioned several times, the importance of the medically integrated team and having the ability for that practice to fill that prescription internally and have robust documentation. Cost avoidance is a critical component that the medically integrated pharmacy, or the MIP, can help the total cost of care. And that is by preventing errant fills or waste that can occur by intervening in the care of the cancer patient, as we do every day. But when the practice has access to the medication and can fill that prescription in-house in the medically integrated pharmacy, that team, that care coordination that takes place, can prevent those errant fills or additional fills when there's dose reductions, there's holidays, there's things that happen in real time. And it's impossible for a mail-order pharmacy that's in another state that has lead times, when a prescription needs to be mailed 7 days or 10 days before the patient will run out of the medication, it's impossible for them to logistically coordinate that care like we can internally within the medically integrated pharmacy. So, we prevent waste and overall cost of care by cost avoidance and having that coordination or that continuity of care that we talk about. And we prevent waste from the mail-order pharmacies by taking that prescription internally and filling it, but also doing it in a way that's more sustainable and cost-effective for all stakeholders in the oncology ecosystem. Brittany Harvey: Absolutely. Thank you both for reviewing those key standards for Domain 2 and touching on the importance of distribution logistics and all the things that a medically integrated pharmacy needs to think through in getting oral anticancer agents to patients. Following that, Michael, we've touched on this a little bit earlier, but how will these updated standards impact clinicians and oncology practices? Michael Reff: Yes, and as Dr. Raez and I have discussed throughout this podcast, these additional standards are there to help support that continuity of care by educating the clinicians that are in the oral anticancer medication space to elevate their provision for these oral therapies. What I mean by that is the practice has to perform at a certain level in order for them to, as I call it, deserve the right to fill that prescription by having the processes and procedures in place. And these standards, these updated or revised standards, are the blueprint for better patient care and to help the practices execute on that journey of continuous improvement. Dr. Luis Raez: Yeah, I only want to add, we have practical examples in the guidelines. We quote a couple of studies that have been successful. And this year, for example, I am a lung cancer doctor, we are presenting in World Lung our standards of adherence to oral oncolytics for EGFR therapy, following the NCODA-ASCO standards. We're around 95% of adherence. We are a healthcare system that is public. We have people with no insurance and a lot of social determinants of health. We are trying to show that it's feasible, even in the most difficult circumstance, when you follow the standards, to be successful. Brittany Harvey: Definitely, these standards can help clinicians and oncology practices succeed in providing these medications. So then beyond that, and to wrap us up, Michael, what do these revised standards mean for patients who are receiving oral anticancer medications? Michael Reff: Yes, great point and question, Brittany, because we have covered the benefits to the clinicians and the practices themselves. But how is this going to support better patient care? And it does it in a whole host of ways. I'll cover just a few of them. What I'm about to share with you relates back to what we call at NCODA the "core claims." Like, what's the core claims of having a medically integrated pharmacy within the practice? And there are seven different core claims that we feel practices that are focused on the continuity of care can deliver better outcomes that are embedded in these standards. And it's talking about abandonment, adherence, access and affordability, speed to therapy or time to fill, as we call it, education, patient satisfaction, and cost avoidance that we covered earlier. So those are the core claims that a practice that follows these revised standards can help elevate. So, faster and more affordable access to the oral cancer medications; individualized support to address barriers like transportation, finance, language, or health literacy, and so on; clear, patient-friendly education; something that is near and dear to all clinicians' hearts, and of course, the patient that was on our panel or on our committee, to empower them to manage side effects and recognize when to seek help; and a stronger partnership with a care team, with regular follow-ups focused on their experience, challenges, and successes; and then, greater overall safety through proactive monitoring for medication errors or complications. So all of these aspects, or tenets, as I'll call them, are baked into these quality standards that are totally aligned with NCODA's core claims document that, again, talks about abandonment, adherence, access and affordability, speed to therapy, education, satisfaction for the patients, and also cost avoidance. Dr. Luis Raez: I only want to add and invite the community to adhere to these standards, to practice the standards. You will be providing the best patient care that we can nowadays. Brittany Harvey: Definitely. I think these standards are very important. And Michael, I thank you for touching on those key claims from NCODA. I think those, along with these updated standards, will improve outcomes for patients everywhere. So I want to thank you both so much for your work to update these standards and all the time you put into it. And thank you for your time today too, Michael and Dr. Raez. Michael Reff: I'd like to thank not only the committee, my esteemed committee that helped support the standards and the revision. Many of the original healthcare providers and patient that were on the first go of the standards were part of the second standards. We revised it, of course, and we got additional support from the new committee. And certainly ASCO and their partnership and collaboration with NCODA has been tremendous. And we look forward to the oncology community at large adopting these standards, again, to work together, we do become stronger, and it will improve cancer care for patients receiving oral anticancer medications. So thank you, Brittany. Dr. Luis Raez: I only want to say the same thing. Actually, there is probably more people in NCODA that is not in the publication that has helped. Same in ASCO. Also, we want to give thanks to Dr. Stephen Grubbs, our leader in quality. He's retiring. We're going to miss him, but he has been a key collaborator with Mike organizing these standards for the last five or six years. So, looking forward to these standards in practice. Brittany Harvey: Absolutely. A big thank you to the entire panel and everyone who contributed to this, and NCODA as well. And then finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the complete standards, go to www.asco.org/standards. I also encourage you to check out the companion episode on these standards on the PQI podcast by NCODA, which you can find on Apple Podcasts and Spotify. You can also find many of our standards and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

In this episode, I'm joined by respected optician and educator Joy Gibb to explore how integrity, empathy, and curiosity—not sales tactics—drive the most impactful optical experiences. Joy introduces the concept of core value dispensing, where product recommendations are rooted in genuine care and a desire to improve each patient's quality of life. We discuss how opticians can uncover lifestyle needs through better questions, collaborate more effectively with doctors, and build lasting trust with patients. Whether you're a doctor, optician, or team leader, this episode offers practical insights to help you elevate care, boost confidence in recommendations, and align your work with what matters most.   Follow our Podcast on All Available Platforms Follow our Podcast on Instagram Follow IDOC on Facebook Follow IDOC on LinkedIn Watch our Podcast Video on YouTube

Join Niki Tudge and Judy Luther as they chat and chuckle with Veronica Sanchez and Jenn Friedline about the damaging effect of dog trainers dispensing poor advice on social media.

SecretBox aims to improve medication adherence and reduce misuse risks. In this episode, Adam Torres and Sofia Carvalho, Founder & CEO at SecretBox, explore Sofia's entrepreneurial journey and SecretBox. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

SecretBox aims to improve medication adherence and reduce misuse risks. In this episode, Adam Torres and Sofia Carvalho, Founder & CEO at SecretBox, explore Sofia's entrepreneurial journey and SecretBox. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode Mark R. Corkins, MD, FAAP, discusses new recommendations for what children should be drinking. Hosts David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, also speak to Kao-Ping Chua, MD, PhD, about a new study on the use of prescription stimulants by U.S. children between the years 2017 and 2023.  For resources go to aap.org/podcast

That Aged Well is in the midst of Nighttime Soap Month, and after taking on two famously crazy ones, Paul and Erika are taking a left turn to watch an episode of the long-running family soap 7th Heaven. And not just any episode…they're talking about the famous one that all revolves around a mystery joint that appears in the family home! Come one, come all, and let us marvel at the messaging!You can follow That Aged Well on Bluesky (@ThatAgedWell.bsky.social), Instagram (@ThatAgedWell), and Threads (@ThatAgedWell)!SUPPORT US ON PATREON FOR BONUS CONTENT!THAT AGED WELL MERCH!Wanna rate and review? HERE YOU GO!Hosts: Paul Caiola & Erika VillalbaProducer & Editor: Paul Caiola

Dispensing aid in the Gaza Strip is becoming increasingly difficult. No one knows this better than Hani. On a professional level, his employer, UNRWA—the main supplier of food, water, and shelter to Gazans over the last year—is banned from operating come 2025. On a personal note, his brother Mahmoud was killed in what Hani believes to have been a targeted strike while operating a soup kitchen for hungry neighbors. Guest: Hani Almadhoun, senior director of philanthropy at UNRWA USA. Want more What Next? Join Slate Plus to unlock full, ad-free access to What Next and all your other favorite Slate podcasts. You can subscribe directly from the What Next show page on Apple Podcasts and Spotify. Or, visit slate.com/whatnextplus to get access wherever you listen. Podcast production by Elena Schwartz, Paige Osburn, Anna Phillips, Madeline Ducharme and Rob Gunther. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dispensing aid in the Gaza Strip is becoming increasingly difficult. No one knows this better than Hani. On a professional level, his employer, UNRWA—the main supplier of food, water, and shelter to Gazans over the last year—is banned from operating come 2025. On a personal note, his brother Mahmoud was killed in what Hani believes to have been a targeted strike while operating a soup kitchen for hungry neighbors. Guest: Hani Almadhoun, senior director of philanthropy at UNRWA USA. Want more What Next? Join Slate Plus to unlock full, ad-free access to What Next and all your other favorite Slate podcasts. You can subscribe directly from the What Next show page on Apple Podcasts and Spotify. Or, visit slate.com/whatnextplus to get access wherever you listen. Podcast production by Elena Schwartz, Paige Osburn, Anna Phillips, Madeline Ducharme and Rob Gunther. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dispensing aid in the Gaza Strip is becoming increasingly difficult. No one knows this better than Hani. On a professional level, his employer, UNRWA—the main supplier of food, water, and shelter to Gazans over the last year—is banned from operating come 2025. On a personal note, his brother Mahmoud was killed in what Hani believes to have been a targeted strike while operating a soup kitchen for hungry neighbors. Guest: Hani Almadhoun, senior director of philanthropy at UNRWA USA. Want more What Next? Join Slate Plus to unlock full, ad-free access to What Next and all your other favorite Slate podcasts. You can subscribe directly from the What Next show page on Apple Podcasts and Spotify. Or, visit slate.com/whatnextplus to get access wherever you listen. Podcast production by Elena Schwartz, Paige Osburn, Anna Phillips, Madeline Ducharme and Rob Gunther. Learn more about your ad choices. Visit megaphone.fm/adchoices

How can B2B marketers - specifically in med tech - improve their insights collection and better understand their audiences? In this episode, our guest Alejandra Ramirez Giles, 

Charles Rose is an unconventional business coach.  While most consultants focus on improving a company's mechanics — sales, marketing, human resources, and the like — his consultancy advises clients on the best ways to unload the personal baggage that limits their bottom line and personal satisfaction. A serial entrepreneur who built an e-commerce company and sold it for $10 million, Charles has since spent 20-plus years instructing CEOs, high-performing professionals, and entrepreneurs on ways to strike a productive balance between business success and life satisfaction. As he explains, on the path to business fulfillment, he explores every aspect of his clients' lives, including physical health, mental health, and personal relations.  Monday Morning Radio is hosted by the father-son duo of Dean and Maxwell Rotbart. Photo: Charles Rose, Transformation CoachingPosted: December 16, 2024 Monday Morning Run Time: 41:29 Episode: 13.27 OPPORTUNITIES OF INTEREST: Blaine Oelkers, America's only chief results officer (Monday Morning Radio 2/6/23), is offering powerful workshops to cap off 2024 and deliver super results in the new year. Selfluence: Your Power to Influence Yourself Blaine's TEDx Talk Dr. Laura Sicola (Monday Morning Radio 2/26/24) co-hosts Alpha Whisperers: Genesis, a podcast mini-series offering a behind-the-scenes examination of the dynamics of power, influence, and leadership. Apple Podcasts Amazon Music Spotify

In his first trip abroad as President-elect, Donald Trump attended the reopening of the Notre Dame Cathedral. Dispensing with protocol, world leaders like Emmanuel Macron are eager to meet with him to take the measure of the man they know as a deliberate disruptor to the world stage. One leader who know him very well is former German Chancellor Angela Merkel. She joined Christiane in Washington to discuss her new memoir "Freedom," how she handled Trump's unconventional style, his fascination with dictators, and Putin's fear tactics. As rebel forces in Syria continue to seize key territories, Christiane digs into the archives, when she visited with Syrian refugees in Jordan, highlighting the ongoing human cost of this 13-year conflict. Sitting down with Christiane in New York, award-winning actress and Hollywood star Demi Moore discusses beauty standards and self-acceptance. She talks about her role in The Substance, a film exploring the dark side of chasing youth, our society's obsession with aging, and opens up about family, and supporting her ex-husband Bruce Willis through his dementia diagnosis. Finally, filmmaker Payal Kapadia discusses her Cannes-winning film "All We Imagine As Light," a poignant exploration of love and patriarchy in modern India. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Everything Remade episode 231. Thanks so much to Rusty for taking the time to chat with me. Intro/Outro track "The Dense Macabre" by Coma Regalia. Featured tracks: 1. Oriska - Helium 2. Eclipse of Eden - Stars to Scars 3. Dispensing of False Halos - Most Fragile Days hear more: oriskacollective.bandcamp.com If you are enjoying what you hear and would like to support the growth of this podcast directly you can do so by way of donation via paypal: middlemanrecords@gmail.com venmo: @ediequinn or join our patreon: patreon.com/humanmachine

Explore how the latest advancements in automotive technology are pushing the boundaries of adhesive applications. We sit down with Joshua Boquist, Head of Sales in Automotive at Delo Industrial Adhesives, to learn about some of the most cutting-edge features of Delo's adhesive applications including low-shrinkage, media-resistant solutions that can withstand extreme temperatures ranging from -40°C to 120°. Joshua also discusses the importance of fast-curing, high-performance adhesives in the EV market, particularly for motors, batteries, and other critical components.Sponsored By:

The word is brandished around quite a bit in the lifestyle. Pushing your kinks onto others especially your partner and having an expectation that they'll fulfil your desires is not the greatest way of tackling your wants and needs. But then how do you approach? how can you feel fulfilled? The panel starts off by address the black n white case of Kink dispensing but moves on to discuss how expressing their kinks and the challenges overcome and those still ahead. We had a great time discussing this most raw and emotional subject. We hope you enjoy it to. Consider subscribing and following us on Twitter for regular updates and to contact us! Have some thoughts or comments for the panel? Please get in contact, we'd love to hear from you!  cuckmylifepod@gmail.com⁠⁠ Get the latest updates! Follow the show on Twitter⁠ ⁠@cuckmylifepod⁠⁠ ⁠ Find the panel on Twitter here

Archangel Michael Speaks Channeled by Jeff Fasano Episode 93 A Message for October 2024 Dispensing Old Belief Systems

Most of us TAKE meds, but all of us can GIVE medicine, the best meds of all!

Mark Layden discusses pharmacy quality outcomes, metrics, and the future direction of justifying clinical pharmacy services.   For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on X @MayoMedE

The question of the day is "Did President Joe Biden POOP his pants while at the 80th anniversary of D-DAY in Normandy, France today? Below is the Daily Beast attempting to debunk it, watch my video as I explore the entire situation and make up your own mind. https://youtu.be/sKXN1yb8hns President Joe Biden delivered a forceful speech Thursday in France to commemorate the 80th anniversary of the D-Day landing, warning that “democracy is not guaranteed” and “the price of unchecked tyranny is the blood of the young and the brave.” MAGA trolls reacted by accusing the president of pooping in his pants. While many observers' attention was focused on the president's address honoring the last living veterans of the invasion of Normandy, the rapid response social media team of the Republican National Committee was instead preoccupied with Biden briefly crouching before taking a seat. In a 13-second clip posted to social media, the president is seen shaking hands with French President Emmanuel Macron before turning toward first lady Jill Biden. He then slightly squats down while reaching for something behind him. The brief video ends with an announcer welcoming Defense Secretary Lloyd Austin to the stage while Jill Biden appears to whisper something to her husband. “Awkward,” the RNC Research account captioned the video, alongside a grimacing face emoji. Pro-Trump influencers and right-wing provocateurs quickly ran wild with the clip, claiming it was definitive proof that the president had soiled his trousers. Dave Rubin, the “ex-lefty turned shitposting Trump stan,” wondered whether Biden was “pooping or sitting in an invisible chair,” adding a poop emoji to his tweet to hammer home the message. Dispensing with Rubin's “just asking questions” framing, beanie aficionado and far-right podcaster Tim Pool blared “HE POOPED” and “HOLY SHIT” in all caps, claiming that the president needed to quickly leave the ceremony to clean himself up. Breaking911, a junk news X (formerly Twitter) account that boasts a million followers, helped spread the narrative to the MAGA masses by reposting the clip with the caption: “Did Biden shit his pants AGAIN?” That would appear to be in reference to a baseless 2021 claim that the Vatican had to cancel a livestream of Biden's meeting with Pope Francis because the president had a “bathroom accident.” Other prominent right-wing media personalities asserted that “there's no way Joe is not pooping himself here” and “Biden just pooped his diaper,” much to the delight of their millions of social media fans. The reality of the situation, though, is far less messy. A couple of seconds after the clip the RNC shared online ends, the president locates the chair behind him and takes a seat alongside the rest of the contingent on stage. Taken in context, Biden seems neither out of place nor in the midst of a bathroom emergency. In fact, it was after this so-called accident or confusion over an “invisible chair” that the president delivered his emotive address while juxtaposing the historic war against the Nazis with the current battles against authoritarianism. “In their generation, in their hour of trial, the Allied forces of D-Day did their duty,” Biden declared. “Now the question for us is, in our hour of trial, will we do ours?” The president's speech received some plaudits from conservative pundits. Bill McGurn, a former George W. Bush speechwriter and Fox News contributor, said Biden “looked in command” and delivered the speech “very well” with “no major stumbles.” But while some Fox News analysts were praising the speech, the conservative cable giant also ran wild with the RNC Research clip to insist that the president is suffering from “spatial disorientation” and that he “appeared confused” on the stage in Normandy. The network's mockery of Biden's supposed confusion was also framed within the context of The Wall Street Journal's recent 3,000-word investigative report that he “shows signs of slipping” behind the scenes, feeding into the GOP's narrative that the 81-year-old president is cognitively impaired. The WSJ article has not only been pilloried by Democrats and liberals, who have labeled it “comically weak,” but also by mainstream media journalists. CNN senior reporter Oliver Darcy lambasted the Journal for largely relying on Republicans to draw “their sweeping conclusion” about the president's mental fitness. “It is difficult to imagine that the newspaper, or any outlet, would run a similar story declaring that Trump is ‘slipping' behind the scenes based on the word of top Democratic figures—despite the fact that the Democratic leadership has demonstrated a much stronger relationship with the truth in recent years than their Republican counterparts,” Darcy noted.

In our economic system, we separate perception from reality. The private sector is a clear and present danger to your health care, and this dialysis story could affect you, too. --- Send in a voice message: https://podcasters.spotify.com/pod/show/politicsdoneright/message

The ability of dialysis providers to banish 'problem' patients proves the private sector does not belong in healthcare. A congressman's truthful words were stricken -- the path to fascism. --- Send in a voice message: https://podcasters.spotify.com/pod/show/politicsdoneright/message

Thanks for tuning in, my friend – In case you're new here, welcome to the Homebrew Happy Hour podcast!… THE home brew #podcast where we answer all of your home brewing questions and discuss anything related to craft beer! A NOT SO SUBTLE REMINDER: If you appreciate the things we do here at Homebrew Happy […]

Interview with Daniel Grossman, MD, author of Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person Screening, and Emily M. Godfrey, MD, MPH, author of Primary Care's Role in Prescribing Mail-Order Mifepristone. Hosted by Eve Rittenberg, MD. Related Content: Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person Screening Primary Care's Role in Prescribing Mail-Order Mifepristone Mifepristone–Science, Abortion Care, and Politics

Cancer care represents a rapidly rising and disproportionate share of overall health care spend. Medically integrated dispensing has been associated with better outcomes, lower waste and better patient care experiences for members receiving. Recognizing this value, payers have developed integrated dispensing networks to supplement traditional dispensing sites; however, little information is available comparing total cost of care. During this conversation with Landon Marshall, health outcomes research principal at Prime/MRx, we take a closer look at the AMCP study, Medically Integrated Dispensing of Oral Oncolytics: Real-World Cost of Care Comparison to Traditional Dispensing. 

In this episode Arwa Nasir, MBBS, MS, MPH, FAAP, chair of the AAP Committee on Psychosocial Aspects of Child and Family Health (COPACFH), describes a recent clinical report on supporting the family after the death of a child. Hosts David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, also speak with Kao-Ping Chua, MD, PhD, FAAP, about his research on the dispensing of antidepressants to adolescents and young adults. And Lindy McGee, MD, FAAP, contributes a “Giving Voice” segment about e-cigarette use within the pediatric population. For resources go to aap.org/podcast.

5pm - ‘Ted Lasso’ star Hannah Waddingham calls out photographer for sexist remark: ‘Don’t be a d–k’ // We’ve been dispensing Tic Tacs incorrectly our entire lives // Study Finds the most Stressful Time of Day is… // Why you should wait 30-60 minutes to brush your teeth after vomiting // The World’s First AI Beauty Pageant! // Things Americans say that make no sense to english speaking foreigners // LETTERS

Candi and Victoria bring you updates on the US Supreme Court case on chemical abortion. Plus, hear Victoria's recent State of the State Address.

In the latest episode of the Wise_N_Nerdy podcast, hosts Joe and Kurt are joined by Stephen from 2DorksTV, making for an engaging and laughter-filled discussion. The episode kicks off with the ever-popular "Question of the Week," delving into the realm of peculiar food experiences. Stephen reminisces about his surprising love for peanut butter and egg sandwiches, while Joe confesses his fondness for dipping cinnamon rolls in chili. Kurt adds to the eclectic mix with his enjoyment of anchovy pizza and Thai chili tuna, setting the tone for a delightfully quirky conversation.After a roll of the dice determines the order, the trio dives into the "What are you Nerding out about?" segment. Stephen shares his adventures with AI in the workplace and his latest endeavors with a 3D printer. Kurt eagerly discusses the newly released live-action adaptation of "Avatar: The Last Airbender" on Netflix, while Joe enthuses over the latest developments in the "Solo Leveling" anime.The podcast takes an interactive turn with several Speakpipes from Charles, detailing his deep dive into the live-action adaptation of "Yu Yu Hakusho." Despite the impending "bad dad joke" segment, the absence of Charles prompts a humorous skip.In the "Daddy tell me a story" segment, Stephen paints a vivid picture of bonding with his son over squatch hunts, showcasing the joys of shared adventures. The discussion then shifts to the practical as the hosts tackle the "How do I...?" segment, offering insights into mastering new programming languages.Wrapping up with the "What do you think about...?" segment, the conversation turns reflective as they contemplate children aspiring to become YouTubers. Dispensing sage advice, the hosts emphasize the importance of hard work and dedication in pursuing one's dreams.As the episode draws to a close, the tagline rings true: "Wise_N_Nerdy: Where Fatherhood Meets Fandom," encapsulating the perfect blend of parental wisdom and nerdy enthusiasm that defines the podcast experience. --- Send in a voice message: https://podcasters.spotify.com/pod/show/wise-n-nerdy/message Support this podcast: https://podcasters.spotify.com/pod/show/wise-n-nerdy/support

Sign up for Dr. Tyna's Ozempic Uncovered⁠: https://www.drtyna.com/a/2147830776/YEo2yxtx Get Dr. Tyna's “Ozempic done right program - https://www.drtyna.com/a/2147830776/YEo2yxtx Social media and the news are filled with the harmful side effects of Ozempic and weight loss injectables. Today I bring on Dr. Tyna Moore to talk about the other side of this topic. Why are so many people coming down so hard on Ozempic? Dr. Tyna has some very interesting information and research that she shares with us today.  Show Links: 21 Day Nervous System Tune Up Healing trauma training Smart Body Smart Mind 12 week program Drtyna.com/ozempicdoneright Check Out Dr. Tyna: The Dr. Tyna Show Instagram YouTube The key moments in this episode are: 03:59 - Dr. Tyna Moore's background 11:20 - Peptides and weight loss 20:05 - Importance of the right dose 24:01 - MDs are held to a standard of care 27:28 - Sustaining weight loss is the hard part 27:48 - Dispensing pens for peptides 28:23 - Addressing weight loss in the first 10-15 lb gain 31:32 - Positive health effects of peptides 35:24 - Fat shaming vs health objectives 38:15 - Misinformation about Ozempic 51:36 - Have a plan and work with a professional 59:05 - Efficacy with Alzheimers and Parkinsons 01:03:39 - Smear campaign and potential notices 01:13:49 - Ozempic Done Right University with Dr. Tyna Sponsored By: Vivarays Use code YOGI to save 15% Upgraded Formulas Use code YOGI12 or YOGI    This video is not medical advice & as a supporter to you and your health journey - I encourage you to monitor your labs and work with a professional! ________________________________________ Get all my free guides and product recommendations to get started on your journey! https://www.sarahkleinerwellness.com/all-free-resources  Use code YOGI for a discount on Blue Blockers at vivarays.com/carnivoreyogi  Use code YOGI or YOGI12 for a discount at www.upgradedformulas.com  Check out all my courses to understand how to improve your mitochondrial health & experience long lasting health! (Use code PODCAST to save 10%) - https://sarah-kleiner.mykajabi.com/store  Sign up for my newsletter to get special offers in the future! - https://sarah-kleiner.mykajabi.com/contact

In the first segment, Jethro unearths spine-tingling stories of encounters with earth-bound spirits. He'll explore firsthand accounts of ghostly apparitions, haunted houses, and inexplicable phenomena that blur the line between the living and the departed. From eerie whispers in the night to chilling encounters with spectral figures, these encounters will send shivers down your spine and leave you pondering the mysteries of the afterlife.In the second half of the episode, Kat journeys through time to explore the unconventional world of currency. Discover the strange and sometimes bizarre objects used as mediums of exchange throughout history. From chunks of tea to giant stone discs and some things you won't believe, Kat unravels the fascinating stories behind these unconventional forms of money. They delve into the cultural and historical contexts that shaped these curious currencies and challenge our conventional notions of trade and value.So, prepare your pork taint for a double dose of curiosity as The Box of Oddities invites you to embark on an extraordinary adventure. Enter into the realm of spirits lurking among us, and uncover the intriguing tales of unusual objects that held value in the past. It is time. Embrace the weird, the mysterious, and the captivating stories that lie within this episode of The Box of Oddities!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.